Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forced diuresis with furosemide versus saline hydration to prevent contrast-induced nephropathy
ACTRN12618000167268Phase 2Completed
- Sponsor
- A/Prof Margaret Arstall
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of furosemide in contrast-induced nephropathy (CIN) (2 arms), sponsored by A/Prof Margaret Arstall. Primary endpoint: Development of contrast-induced nephropathy. Started Aug 2017; status: completed.
02
Drugs
furosemide
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on ACTRN12618000167268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000167268.